A phase II study of primary reirradiation in squamous cell carcinoma of head and neck

Radiotherapy and Oncology

Volumn 78, Issue 3, 2006, Pages 306-312

  Langendijk, Johannes A ^a   Kasperts, Nicolien ^a   Leemans, Charles R ^b   Doornaert, Patricia ^a   Slotman, Ben J ^a  

^a Department of Radiation Oncology ^*  (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Head and neck cancer; Recurrence; Reirradiation; Second primary

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; DISEASE SEVERITY; DYSPHAGIA; FEMALE; FOLLOW UP; HEAD AND NECK CARCINOMA; HUMAN; IRRADIATION; MALE; MORBIDITY; MUCOSA INFLAMMATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION DOSE; RADIATION DOSE FRACTIONATION; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; SURVIVAL TIME; TARGET ORGAN; TOXICITY; TREATMENT OUTCOME; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NETHERLANDS; RADIATION INJURIES; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 33646468697     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2006.02.003     Document Type: Article

References (25)

1. Benchalal M., Bachaud J.M., Francois P., et al. Hyperfractionation in the reirradiation of head and neck cancers. Results of a pilot study. Radiother Oncol 36 (1995) 203-210
2. Brockstein B., Haraf D.J., Stenson K., et al. A phase I-II study of concomitant chemoradiotherapy with paclitaxel (one-hour infusion), 5-fluorouracil and hydroxyurea with granulocyte colony stimulating factor support for patients with poor prognosis head and neck cancer. Ann Oncol 11 (2000) 721-728
3. Browman G.P., and Cronin L. Standard chemotherapy in squamous cell head and neck cancer: what we have learned from randomized trials. Semin Oncol 21 (1994) 311-319
4. Budach V.G., Geismar D., Lammert I., et al. Hyperfractionated accelerated chemoradiation with concurrent fluorouracil-mitomycin is more effective than dose-escalated hyperfractionated accelerated radiation therapy alone in locally advanced head and neck cancer: final results of the radiotherapy cooperative clinical trials group of the German Cancer Society 95-06 Prospective Randomized Trial. J Clin Oncol 3 (2005) 1125-1135
5. Dawson L.A., Myers L.L., Bradford C.R., et al. Conformal re-irradiation of recurrent and new primary head-and-neck cancer. Int J Radiat Oncol Biol Phys 50 (2001) 377-385
6. De Crevoisier R., Bourhis J., Domenge C., et al. Full-dose reirradiation for unresectable head and neck carcinoma: experience at the Gustave-Roussy Institute in a series of 169 patients. J Clin Oncol 16 (1998) 3556-3562
7. Fu K.K., Pajak T.F., Trotti A., et al. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys 48 (2000) 7-16
8. Gandia D., Wibault P., Guillot T., et al. Simultaneous chemoradiotherapy as salvage treatment in locoregional recurrences of squamous head and neck cancer. Head Neck 15 (1993) 8-15
9. Grau C., Hansen H.S., Specht L., et al. Acute and late normal tissue reactions in the DAHANCA 6&7 randomized trial with accelerated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 57 (2003) S154
10. Haraf D.J., Weichselbaum R.R., and Vokes E.E. Re-irradiation with concomitant chemotherapy of unresectable recurrent head and neck cancer: a potentially curable disease. Ann Oncol 7 (1996) 913-918
11. Haughey B.H., Gates G.A., Arfken C.L., and Harvey J. Meta-analysis of second malignant tumours in head and neck cancer: the case for an endoscopic screening protocol. Ann Otol Rhinol Laryngol 101 (1992) 105-112
12. Horiot J.C., Bontemps P., van den Bogaert W., et al. Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial. Radiother Oncol 44 (1997) 111-121
13. Hong W.K., Bromer R.H., Amato D.A., et al. Patterns of relapse in locally advanced head and neck cancer patients who achieved complete remission after combined modality therapy. Cancer 56 (1985) 1242-1245
14. Langlois D., Eschwege F., Kramar A., and Richard J.M. Reirradiation of head and neck cancers. Presentation of 35 cases at the Gustave Roussy Institute. Radiother Oncol 3 (1985) 27-33
15. Overgaard J., Hansen H.S., Specht L., et al. Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial. Lancet 362 (2003) 933-940
16. Pignon J.P., Bourhis J., Domenge C., and Designe L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-analysis of chemotherapy on head and neck cancer. Lancet 355 (2000) 949-955
17. Ruifrok A.C., Kleiboer B.J., and van der Kogel A.J. Reirradiation tolerance of the immature rat spinal cord. Radiother Oncol 23 (1992) 249-256
18. Schaefer U., Micke O., Schueller P., and Willich N. Recurrent head and neck cancer: retreatment of previously irradiated areas with combined chemotherapy and radiation therapy-results of a prospective study. Radiology 216 (2000) 371-376
19. Spencer S.A., Wheeler R.H., Peters G.E., et al. Concomitant chemotherapy and reirradiation as management for recurrent cancer of the head and neck. Am J Clin Oncol 22 (1999) 1-5
20. Spencer S.A., Harris J., Wheeler R.H., et al. RTOG 96-10: reirradiation with concurrent hydroxyurea and 5-fluorouracil in patients with squamous cell cancer of the head and neck. Int J Radiat Oncol Biol Phys 51 (2001) 1299-1304
21. Stevens Jr. K.R., Britsch A., and Moss W.T. High-dose reirradiation of head and neck cancer with curative intent. Int J Radiat Oncol Biol Phys 29 (1994) 687-698
22. Skolyszewski J., Korzeniowski S., and Reinfuss M. The reirradiation of recurrences of head and neck cancer. Br J Radiol 53 (1980) 462-465
23. Vokes E.E., Panje W.R., Schilsky R.L., et al. Hydroxyurea, fluorouracil, and concomitant radiotherapy in poor-prognosis head and neck cancer: a phase I-II study. J Clin Oncol 7 (1989) 761-768
24. Wang C.C., and McIntyre J. Re-irradiation of laryngeal carcinoma-techniques and results. Int J Radiat Oncol Biol Phys 26 (1993) 783-785
25. Weppelmann B., Wheeler R.H., Peters G.E., et al. Treatment of recurrent head and neck cancer with 5-fluorouracil, hydroxyurea, and reirradiation. Int J Radiat Oncol Biol Phys 22 (1992) 1051-1056